The weight-loss medication Wegovy could offer a new treatment option for children as young as 6 living with severe obesity, according to a major international clinical trial that found substantial improvements in body mass index (BMI) among young patients receiving weekly injections.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Or
Contact Or, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack